Interactive Decision Support Tool


Share

Program Content

Activities

  • CML IDST
    Expert Guidance on Monitoring Response to BCR-ABL1 Inhibitors in CML: An Interactive Decision Support Tool
    Tool
    Congratulations: You achieved a completion on 04/09/2022

    Released: January 07, 2025

    Expires: January 06, 2026

Provided by

ProCE Banner

Supporters

Supported by educational grants from Bristol Myers Squibb and Novartis Pharmaceuticals Corporation.

Bristol Myers Squibb

Novartis Pharmaceuticals Corporation